GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, GSK3B, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MMP2, MMP9, PPARA, PTAFR, PTGS2, SRC, TYR |
13.8111 |
[BP] GO:0044281 |
small molecule metabolic process
|
ABCG2, AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, FUT7, GBA2, GLO1, HMGCR, IDO1, PIM1, PPARA, PTAFR, PTGS2, TYR, XDH |
11.515 |
[BP] GO:0008152 |
metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
11.515 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
11.515 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PTGS2 |
10.9566 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PHF8, PTGS2, TYR, XDH |
10.9566 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, PTAFR, PTGS2, SRC, TYR |
10.8974 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
10.6399 |
[BP] GO:0042221 |
response to chemical
|
ABCG2, AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP2, MMP9, PPARA, PTAFR, PTGS2, SRC, TYR |
10.5973 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.54842 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCG2, ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, PPARA, PTAFR, PTGS2, SRC, TNKS, TNKS2, XDH |
8.95483 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FLT3, HSD11B2, PTAFR, PTGS2, SRC, TYR |
8.92346 |
[BP] GO:0044237 |
cellular metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP2, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
8.33839 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, SRC, TNKS2, TOP2A, TYR |
8.10668 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
8.08499 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
8.01662 |
[BP] GO:0042493 |
response to drug
|
ABCG2, AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, FABP3, HMGCR, HSD11B2, KDR, PTAFR, PTGS2, SRC |
7.92656 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC |
7.56736 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
7.55578 |
[BP] GO:0071704 |
organic substance metabolic process
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.55578 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2, SRC, XDH |
7.40827 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
7.39892 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
7.39892 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
7.03057 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.98897 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, PTAFR, PTGS2, SRC |
6.92946 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.84405 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
6.39035 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
6.30574 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
6.29126 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC |
6.25724 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.18274 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
6.14188 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC |
6.14188 |
[BP] GO:0050896 |
response to stimulus
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC, TOP2A, TYR |
6.13031 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.08076 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
6.05228 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
6.0011 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
5.76954 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
5.76954 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, GSK3B, HMGCR, IDO1, KDR, MET, MMP12, MMP2, MMP9, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
5.76787 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, DHFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
5.7197 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CNR1, CNR2, CYP19A1, DHFR, ESR1, F3, FABP4, GSK3B, HMGCR, IDO1, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, XDH |
5.6205 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTAFR, PTGS2, SRC, TNKS2, TYR |
5.60968 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA, PTGS2 |
5.53181 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC |
5.49424 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.41506 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTAFR, PTGS2 |
5.29374 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, CNR1, HMGCR, KDR, PTGS2, SRC, TNKS, TNKS2 |
5.27892 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, IDO1, PPARA, PTGS2 |
5.24233 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DHFR, ESR1, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
5.21576 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
5.14306 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
5.06681 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
5.03905 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, GBA2, HMGCR, PTAFR, TYR |
5.02146 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PHF8, PPARA, SRC, TYR |
4.99758 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.98608 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
4.9797 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTAFR, PTGS2, SRC |
4.88343 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, PTAFR, PTGS2, SRC |
4.84799 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, MMP2, MMP9, PTAFR, PTGS2, SRC, TOP2A |
4.83374 |
[BP] GO:0006082 |
organic acid metabolic process
|
ABCG2, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS2, TYR |
4.83374 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIM1, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
4.8087 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, HMGCR, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.77145 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS2, TYR |
4.76599 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.69911 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, GSK3B, HSD11B1, HSD17B2, KDR, MMP9, PHF8, PIM1, PPARA, PTGS2, SRC, TYR |
4.69911 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.69911 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.64261 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS2 |
4.62354 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.59445 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
4.59445 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
4.58744 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
4.57215 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PTGS2 |
4.55033 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
4.51443 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.51443 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, PIM1, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
4.50721 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
4.47017 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39221 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR, IDO1 |
4.37699 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTAFR, PTGS2, PTPN1, SRC, TOP2A |
4.27821 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.27821 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, F3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC |
4.2768 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS2, TYR |
4.27288 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
4.17011 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
4.15249 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
4.15249 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
4.10955 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.10955 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CDK6, CYP1B1, ESR1, GSK3B, IGF1R, MMP2, MMP9, PTAFR, PTGS2, SRC |
3.99567 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, HSD11B2, IGF1R, PPARA, PTGS2, SRC |
3.96605 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTAFR, PTGS2, SRC |
3.94845 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
3.94845 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
3.85035 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, F3, FABP4, HMGCR, IDO1, KDR, MET, MMP12, PPARA, PTGS2 |
3.81974 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC |
3.81937 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KDR, PTAFR, PTGS2, SRC |
3.79653 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESR2, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
3.70358 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DHFR, ESR1, F3, FABP4, FLT3, GSK3B, HMGCR, IGF1R, MMP9, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
3.70358 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.66512 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
3.64637 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, PTAFR, PTGS2, SRC |
3.63481 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, PTAFR, PTGS2, SRC |
3.57046 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.5689 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.5689 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.56272 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, GSK3B, IDO1, MMP12, PTAFR, PTGS2, SRC |
3.49621 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
3.49621 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
3.473 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, BCL2, CYP1B1, F3, FLT3, HMGCR, KDR, MET, PTGS2, PTPN1, SRC, XDH |
3.473 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
3.46153 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, HSD17B2, KDR, MMP2, PTAFR, PTGS2, SRC |
3.38441 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.37129 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.37129 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HMGCR, HSD11B2, MMP2, PPARA, PTAFR, PTGS2, SRC, TYR |
3.35208 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DHFR, IDO1 |
3.30934 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.29221 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.27865 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, KDR, MET, MMP2, MMP9, PTGS2, SRC, TOP2A |
3.27167 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, PTGS2, SRC, TYR |
3.26084 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, F3, FABP4, FLT3, GSK3B, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, XDH |
3.23894 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
3.22806 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS2, SRC |
3.20765 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TNKS |
3.20765 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
3.18698 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HMGCR, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
3.18418 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC |
3.18393 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CDK6, CNR1, CYP1B1, ESR1, ESRRA, ESRRB, F3, GSK3B, HMGCR, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTAFR, PTGS2, SRC, TNKS2, XDH |
3.18166 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
3.15958 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PTGS2 |
3.15958 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, PTAFR |
3.13086 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.13086 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
3.12972 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC |
3.1081 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
3.08038 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.07943 |
[BP] GO:0042592 |
homeostatic process
|
ABCG2, ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, ESR1, FABP3, FABP4, FLT3, MET, SRC |
3.07943 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, PTAFR, PTGS2, SRC |
3.05996 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HMGCR, PPARA, PTGS2, SRC |
3.051 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PTAFR, PTGS2 |
3.02556 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CNR1, CYP1B1, ESRRB, F3, HMGCR, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTAFR, PTGS2, SRC |
3.01139 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.99424 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.99424 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B2, IDO1, MMP2, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC, TOP2A |
2.96193 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.95144 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MMP9, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.95144 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, GSK3B, PPARA, SRC, TOP2A |
2.94711 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CNR1, CNR2, CYP1A1, CYP1A2, HMGCR, HSD11B2, IDO1, MMP12, PTAFR, PTGS2, SRC, TYR |
2.94276 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F3, IGF1R, KDR, MET, MMP9, PTAFR, PTGS2, SRC |
2.87976 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC |
2.87976 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, ESR1, FABP4, IDO1, PPARA, PTGS2 |
2.85324 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, HSD11B2, PTAFR, PTGS2 |
2.85148 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82544 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.82544 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, ESR1, ESR2, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH |
2.82544 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTAFR, PTGS2 |
2.82343 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.81528 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, ESR1, ESR2, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, XDH |
2.81528 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, PTGS2 |
2.80944 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, PTGS2 |
2.80944 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AURKB, BCL2, CNR1, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.80778 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HMGCR, SRC, TNKS, TNKS2 |
2.79946 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.77254 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.75163 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, PPARA, PTAFR |
2.75163 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, HMGCR, HSD11B2, PTGS2, SRC, TYR |
2.75163 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, HSD11B2, PPARA, PTAFR, PTGS2 |
2.72781 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, HMGCR, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.72002 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CNR1, ESR1, GSK3B, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.70571 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, PTGS2, TNKS, TNKS2 |
2.70571 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PHF8, PPARA, PTAFR, PTGS2, SRC, TNKS, TNKS2, TOP2A |
2.69317 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.65974 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.65919 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CNR1, CYP1A1, HMGCR, PTGS2 |
2.65467 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.59564 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.59294 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.59294 |
[BP] GO:0009987 |
cellular process
|
ABCG2, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.58073 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.55631 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, DHFR, HMGCR, PTAFR, TYR |
2.55631 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESRRA, IDO1, MMP12, MMP2, PTAFR, PTPN1, SRC |
2.54772 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.53169 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.5287 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, DHFR, HMGCR, IDO1, PTAFR, PTGS2 |
2.52579 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.50555 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.49717 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, XDH |
2.46992 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.46844 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.46844 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, ESR1, FLT3, GSK3B, IGF1R, MMP2, PTAFR, PTGS2, SRC |
2.46836 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, GSK3B, KDR, SRC |
2.46038 |
[BP] GO:0010676 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.45235 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.45235 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.45235 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.4297 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.42474 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.41275 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, BCL2, CDC25B, DHFR, ESR1, ESR2, F3, FLT3, GSK3B, MET, MMP9, PTAFR, PTPN1, SRC, TNKS, XDH |
2.41191 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.39075 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DHFR, PPARA |
2.35903 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.35024 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ABCG2, ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.33352 |
[BP] GO:2001251 |
None
|
PHF8, SRC, TNKS, TNKS2, TOP2A |
2.33081 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PHF8, PPARA, PTAFR, PTGS2, SRC, TNKS, TNKS2, TOP2A |
2.31267 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FLT3, HMGCR, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.31267 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.29629 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GSK3B, HMGCR, KDR, MMP9, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.28795 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.28332 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TNKS, TNKS2, XDH |
2.2785 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PTGS2, SRC |
2.27087 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.27087 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, PHF8 |
2.27087 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.25342 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, APP, CYP1B1, DHFR, HMGCR, PTAFR |
2.25342 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, BCL2, CBR1, CDK6, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, GSK3B, HMGCR, KDR, MMP2, MMP9, PTGS2, TOP2A |
2.25153 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.25019 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.25019 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GSK3B, IGF1R, KDR, MET, MMP2, MMP9, PTAFR, PTPN1, SRC, TNKS, TNKS2 |
2.24476 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, F3, FABP4, IDO1, KDR, MET, PTGS2 |
2.23201 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.22672 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, HMGCR, PTGS2, TYR |
2.21555 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.21256 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, SRC, TNKS, TOP2A |
2.21256 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.21256 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.21256 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.21256 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.21256 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.21256 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21256 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.19894 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, PPARA, PTAFR, SRC |
2.19894 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PHF8, PPARA, PTAFR, SRC, TNKS, TNKS2, TOP2A |
2.19107 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.18984 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CNR1, CNR2, CSNK2A1, FABP4, GSK3B, HMGCR, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.18984 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.17337 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, PTGS2 |
2.17337 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.17337 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17074 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, HMGCR, IGF1R, KDR, MMP9, PPARA, PTGS2, PTPN1, SRC, XDH |
2.16957 |
[BP] GO:1901360 |
None
|
ABCG2, ACHE, AKR1B1, AKR1B10, AOX1, APEX1, APP, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PHF8, PPARA, PTGS2, TOP2A, TYR, XDH |
2.15779 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15347 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.15137 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.15137 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, GSK3B, HMGCR, MMP12, MMP9, PPARA, PTAFR, PTGS2, PTPN1, SRC |
2.13652 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.10044 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESR1, F3, FLT3, GSK3B, HMGCR, KDR, MMP9, PTAFR, PTGS2, PTPN1, SRC, XDH |
2.09057 |
[BP] GO:0045913 |
None
|
ESRRB, PPARA, PTAFR, SRC |
2.08697 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, SRC |
2.08529 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.08529 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08529 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, PTAFR, PTGS2, TYR |
2.08529 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, GBA2, GSK3B, IDO1, SRC, XDH |
2.08395 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CDK6, CNR1, CNR2, CYP19A1, IDO1, MMP12 |
2.0793 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DHFR, GSK3B, HMGCR, IGF1R, MET, PTGS2, PTPN1, XDH |
2.05586 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.04711 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.04711 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.04711 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.04711 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.04711 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, MET, PIM1, SRC, TYR |
2.04237 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AXL, BCL2, CA2, CDK6, CNR1, CYP1B1, ESR1, ESRRA, F3, GSK3B, HMGCR, IDO1, KDR, PIM1, PTGS2, SRC, XDH |
2.03917 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.03917 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.03181 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, PIM1, TNKS, TOP2A |
2.0208 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, FLT3 |
2.01779 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.01635 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.01635 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00446 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.00446 |
[CC] GO:0044444 |
cytoplasmic part
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, KDR, MMP2, MMP9, PIM1, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.74466 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2, PTPN1 |
2.80944 |
[CC] GO:0016020 |
membrane
|
ABCG2, ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP2, PHF8, PIM1, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TYR |
2.80944 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTGS2 |
2.58285 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, BCL2, CA4, CYP19A1, FLT3, GBA2, HMGCR, KDR, PTGS2, PTPN1, XDH |
2.49406 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTPN1, TNKS, TYR, XDH |
15.6109 |
[MF] GO:0003824 |
catalytic activity
|
ABCG2, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
14.0435 |
[MF] GO:0043167 |
ion binding
|
ABCG2, ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HMGCR, HSD17B1, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
12.5897 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, PHF8, PTGS2, TYR, XDH |
11.5488 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1844 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PHF8, PPARA, PTPN1, TNKS |
7.31451 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
7.30234 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, HMGCR, HSD11B2, HSD17B1, IDO1, PTGS2, SRC, XDH |
6.91329 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.81527 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.74193 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PHF8, XDH |
6.70674 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.61787 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PHF8, PIM1, PPARA, PTGS2, PTPN1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.49777 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, PTGS2, SRC |
6.30574 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.25271 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, IDO1, PTGS2, SRC |
6.08917 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PHF8, PTGS2, TYR |
5.70686 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.37488 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.23178 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.14306 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.82345 |
[MF] GO:0008144 |
drug binding
|
ABCG2, ACHE, AURKB, AXL, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
4.54047 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.92832 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.86384 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.76517 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.76517 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.41104 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.37361 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.37129 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.32449 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.27167 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, PTAFR |
3.1081 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.04829 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.90106 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.84894 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.82544 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.82544 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.82544 |
[MF] GO:0042802 |
identical protein binding
|
ABCG2, ACHE, AOX1, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTGS2, TOP2A, TYR, XDH |
2.74036 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.68577 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, ESR1, ESR2, ESRRB, F3, GSK3B, HMGCR, MET, PPARA, PTAFR, PTGS2, PTPN1, SRC, TNKS2, TOP2A |
2.61435 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.60868 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.54772 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, PPARA, PTAFR |
2.53509 |
[MF] GO:0036094 |
small molecule binding
|
ABCG2, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH |
2.46321 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.45235 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CDK6, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, PPARA, PTAFR |
2.3373 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.3373 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.21256 |
[MF] GO:0043168 |
anion binding
|
ABCG2, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DHFR, F3, FABP3, FABP4, FLT3, GSK3B, HMGCR, HSD17B1, IGF1R, KDR, MET, PIM1, PTAFR, SRC, TOP2A, XDH |
2.17337 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.12659 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.08529 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.04711 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.04711 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, MET, PPARA, PTAFR |
2.04711 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04711 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.01635 |
[MF] GO:0000166 |
nucleotide binding
|
ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH |
2.00446 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCG2, ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, IDO1, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.00446 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCG2, AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MET, PIM1, SRC, TOP2A, XDH |
2.00446 |